Industry Developments

German generic firm Stada intends to resist a takeover, remain independent and seek acquisitions, according to a statement made by CEO Hartmut Retzlaff at the company's annual financial... 2006-04-05

German firm Boehringer Ingelheim has opened a EUR50mn (US$61.3mn) manufacturing and R&D facility at its base in Biberach, Germany.

The majority of Spain's political parties have reached a consensus on the controversial proposed medicines bill, after the congress' healthcare commission approved a further 16 amendments... 2006-04-05

US-based Wyeth and the Health Ministry of Scotland have collaborated and created the Translational Medicine Research Collaboration (TMRC). The TMRC - funded by US$86mn from Wyeth... 2006-04-04

Clinical trials in the UK have come under the spotlight since the TeGenero disaster in March when the first six healthy volunteers who took the monoclonal antibody under investigation... 2006-04-03

India's Ranbaxy has acquired Ethimed - the tenth largest generics firm in Belgium - as part of its European expansion plan. No financial details were released but the deal was described... 2006-03-31

The Swiss regulatory authority - Swissmedic - has approved Bayer and Onyx Pharmaceuticals' Nexavar (sorafenib) for the treatment kidney cancer. The drug is already approved in the... 2006-03-31

Dutch biotechnology firm Crucell is to sell its biopharmaceutical and vaccine manufacturing business - Rhein Biotech GmbH - to US company Dynavax Technologies for EUR10mn (US$12.1mn).... 2006-03-30

Spain's autonomous regions owe more than EUR2bn to pharmaceutical companies and figure is rising, according to industry association Farmaindustria. Valencia owes the most (EUR607mn;... 2006-03-30

Indian firm Ranbaxy Laboratories is to acquire Allen SpA - the Italian generic business of UK drug major GlaxoSmithKline (GSK) - through its local subsidiary, Ranbaxy Italia. The... 2006-03-28